Search - tctmd.com

Displaying 781 - 800 of 1163

Sort: Relevancy | Date

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Presentation TCT 2017

TAVR in Low-Risk Patients

Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim

October 29, 2017

Presentation TCT 2017

Valve Thrombosis and Durability

Presenter: Jeroen J. Bax, Axel Linke, Lars Sondergaard

October 29, 2017

Presentation TCT 2017

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian

October 29, 2017

Presentation TCT 2017

Case Conclusion: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk My Approach and Outcome

Presenter: Fazila T. Malik, Jack Wei Chieh Tan, Sodiqur Rifqi

October 29, 2017

Presentation TCT 2017

Hemodynamics of Aortic Stenosis

Presenter: Thomas H. Maloney, Jeff Davis

October 29, 2017

Presentation TCT 2017

Case Introduction: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk

Presenter: Fazila T. Malik, Jack Wei Chieh Tan, Sodiqur Rifqi

October 29, 2017

Presentation CDM 2017

Lower Extremity Revascularization A Critical Appraisal for Endovascular Therapy

Presenter: Lawrence A. Garcia

October 06, 2017

Presentation PCR London Valves 2017

Challenging TAVI Case of Bicuspid Aortic Stenosis

Presenter: Praveen Chandra

September 27, 2017

Presentation PCR London Valves 2017

Aortic Stenosis: Anatomy, Physiology and Pathology

Presenter: Marjo de Ronde-Tillmans

September 25, 2017

Presentation iASSESS 2017

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Rahul Sakhuja, Zoltan Turi

August 30, 2017

Presentation iASSESS 2017

Mitral Valve Stenosis, Tricuspid and Pulmonic Valve Disease

Presenter: Payam Dehghani

August 30, 2017

Presentation SOLACI 2017

Is the PCI risk higher in patients with severe aortic stenosis? How can we reduce the risk?

Presenter: Daniel Weilenmann

August 02, 2017

Presentation TVT 2017

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Presenter: David J. Cohen, Jeffrey J. Popma, Robert O. Bonow

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Presentation TVT 2017

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

Presenter: David J. Cohen, Jeffrey J. Popma, Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon

June 16, 2017

Presentation TVT 2017

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Presenter: Howard C. Herrmann

June 16, 2017

Advertisement

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

TAVR in Low-Risk Patients

Valve Thrombosis and Durability

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Case Conclusion: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk My Approach and Outcome

Hemodynamics of Aortic Stenosis

Case Introduction: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk

Lower Extremity Revascularization A Critical Appraisal for Endovascular Therapy

Challenging TAVI Case of Bicuspid Aortic Stenosis

Aortic Stenosis: Anatomy, Physiology and Pathology

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Mitral Valve Stenosis, Tricuspid and Pulmonic Valve Disease

Is the PCI risk higher in patients with severe aortic stenosis? How can we reduce the risk?

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content